Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review

BACKGROUND: Guidelines recommend that treatment with a long-acting β(2) agonist (LABA), a long-acting muscarinic antagonist (LAMA), and inhaled corticosteroids (ICS), i.e. triple therapy, is reserved for a select group of symptomatic patients with chronic obstructive pulmonary disease (COPD) who con...

Descripción completa

Detalles Bibliográficos
Autores principales: Langham, Sue, Lewis, Jen, Pooley, Nick, Embleton, Nina, Langham, Julia, Han, MeiLan K., Chalmers, James D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829989/
https://www.ncbi.nlm.nih.gov/pubmed/31684965
http://dx.doi.org/10.1186/s12931-019-1213-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829989/
https://www.ncbi.nlm.nih.gov/pubmed/31684965
http://dx.doi.org/10.1186/s12931-019-1213-9

Ejemplares similares